Armepavine

CAS No. 524-20-9

Armepavine( —— )

Catalog No. M18725 CAS No. 524-20-9

Armepavine exerted both in vitro and in vivo antifibrotic effects in rats, with inhibition of NF-κB, JunD and C/EBP pathways.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 263 In Stock
10MG 448 In Stock
25MG 721 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Armepavine
  • Note
    Research use only, not for human use.
  • Brief Description
    Armepavine exerted both in vitro and in vivo antifibrotic effects in rats, with inhibition of NF-κB, JunD and C/EBP pathways.
  • Description
    Armepavine exerted both in vitro and in vivo antifibrotic effects in rats, with inhibition of NF-κB, JunD and C/EBP pathways. It improves experimental autoimmune crescentic glomerulonephritis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    IκB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    524-20-9
  • Formula Weight
    313.39
  • Molecular Formula
    C19H23NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (319.09 mM)
  • SMILES
    CN1CCc2cc(c(cc2[C@H]1Cc1ccc(cc1)O)OC)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Weng TC, et al. Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats. Phytother Res. 2012 Mar;26(3):344-53.
molnova catalog
related products
  • Ragifilimab

    Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody that targets glucocorticoid-induced TNFR-associated protein (GITR) and can be used in the study of advanced or metastatic solid tumors.

  • Bergamotine

    Bergamotine can significantly reduce blood glucose and increase glucose tolerance and insulin sensitivity in diabetic mice.

  • Utomilumab

    Utomilumab (PF 05082566) is a humanized IgG2 antibody that targets the T-cell co-stimulatory receptor 4-1BB/CD137 and acts as a 4-1BB/CD137 agonist.